IMPLANTS BY DR UZMAN LIMITED

IMPLANTS BY DR UZMAN LIMITED
Statement of Financial Position
As at 30 April 2025

	Notes	2025 £	2024 £
Fixed assets
Tangible fixed assets	3	5,606	5,894
		5,606	5,894
Current assets
Debtors	4	18,974	641
Cash at bank and in hand		12,421	18,122
		31,395	18,763
Creditors: amount falling due within one year	5	(29,890)	(18,881)
Net current assets		1,505	(118)

Total assets less current liabilities		7,111	5,776
Provisions for liabilities	6	(1,474)	(1,474)
Net assets		5,637	4,302

Capital and reserves
Profit and loss account		5,637	4,302
Shareholders' funds		5,637	4,302

For the year ended 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director on 15 January 2026 and were signed by:

-------------------------------
Dr Uzman UL HAQ
Director

IMPLANTS BY DR UZMAN LIMITED
Notes to the Financial Statements
For the year ended 30 April 2025

General Information

IMPLANTS BY DR UZMAN LIMITED is a private company, limited by shares, registered in , registration number 14027298, registration address 61 High Street, Great Linford, Milton Keynes, England, MK14 5AX.

The presentation currency is £ sterling.

Accounting policies

Significant accounting policies

Statement of compliance

These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.

The financial statements are prepared in sterling which is the functional currency of the company.

Turnover

Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.

Operating lease rentals

Rentals payable under operating leases are charged against income on a straight line basis over the lease term.

Taxation

Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted

Intangible assets

Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable.

Tangible fixed assets

Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:

Fixtures and Fittings	10% Reducing Balance
Computer Equipment	25% Reducing Balance

Provisions

Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.

2.	Average number of employees Average number of employees during the year was 1 (2024 : 1).

Tangible fixed assets

Cost or valuation	Fixtures and Fittings	Computer Equipment	Total
	£	£	£
At 01 May 2024	7,215	-	7,215
Additions	-	402	402
Disposals	-	-	-
At 30 April 2025	7,215	402	7,617
Depreciation
At 01 May 2024	1,321	-	1,321
Charge for year	589	101	690
On disposals	-	-	-
At 30 April 2025	1,910	101	2,011
Net book values
Closing balance as at 30 April 2025	5,305	301	5,606
Opening balance as at 01 May 2024	5,894	-	5,894

Debtors: amounts falling due within one year

	2025 £	2024 £
Other Debtors	641	641
Directors' Current Accounts	18,333	0
	18,974	641

Creditors: amount falling due within one year

	2025 £	2024 £
Bank Loans & Overdrafts (Secured)	(3,354)	0
American Express	4,896	(3,922)
Corporation Tax	28,348	19,445
Accrued Expenses	0	3,358
	29,890	18,881

Provisions for liabilities

	2025 £		2024 £
Deferred Tax	1,474		1,474
	1,474		1,474

Share Capital

Authorised
100 Class A shares of £1.00 each

Allotted, called up and fully paid	2025 £		2024 £
100 Class A shares of £1.00 each	100		100
	100		100

Registered Number: 14027298

IMPLANTS BY DR UZMAN LIMITED

Unaudited Financial Statements

Period of accounts Start date: 01 May 2024 End date: 30 April 2025